MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s41747-026-00724-z

Медицинская библиотека · European radiology experimental · 2026

Combining DMI and [18F]FDG-PET can complement the assessment of metabolic dysfunction-associated fatty liver disease.

Ehret Viktoria, Ustsinau Usevalad, Fürnsinn Clemens, Scherer Thomas, Starčuková Jana, Hacker Marcus, Krššák Martin, Philippe Cécile

СтатьяПеревод пока не подготовлен

Аннотация

The unique capability of deuterium metabolic imaging (DMI) to detect downstream metabolic products and trace substrates' transport within tissues using conventional magnetic resonance (MR) scanners can, in theory, be employed with routine positron emission tomography (PET)/MR equipment. Our technical proof-of-concept study proposes a protocol for the simultaneous acquisition of DMI and [¹⁸F]FDG-PET data to enable dual assessment of hepatic glucose metabolism. A protocol that integrates high-dose glucose administration, required for DMI, with [¹⁸F]FDG-PET imaging was applied in a spectroscopy-validated rodent model of metabolic dysfunction-associated fatty liver disease (MAFLD). We acquired and quantified high-quality DMI and PET data of the liver that could provide a distinction between healthy and MAFLD cohorts in the future. RELEVANCE STATEMENT: This proof-of-concept study demonstrates the simultaneous DMI-[18F]FDG-PET acquisition for assessing hepatic glucose metabolism. With its proven viability in healthy and MAFLD livers, hybrid DMI-PET imaging shows promise as a prospective non-invasive tool to improve metabolic disease characterization and support future research applications. KEY POINTS: Simultaneous DMI and [¹⁸F]FDG-PET acquisition is technically feasible on a standard PET/MR system. Hybrid DMI-PET imaging enables dual assessment of hepatic glucose transport and metabolism, offering the advantage of reduced assessment duration. High-dose glucose administration for DMI is compatible with PET imaging, thereby reducing the subject's burden and enhancing liver metabolic evaluation.

Для цитирования: Ehret Viktoria, Ustsinau Usevalad, Fürnsinn Clemens, Scherer Thomas, Starčuková Jana, Hacker Marcus, Krššák Martin, Philippe Cécile. Combining DMI and [18F]FDG-PET can complement the assessment of metabolic dysfunction-associated fatty liver disease.. European radiology experimental. 2026. DOI: 10.1186/s41747-026-00724-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.